Waldenstrom Macroglobulinemia Clinical Trials

A listing of Waldenstrom Macroglobulinemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Duarte California 91010

A clinical research study of ABT199 for the treatment of Waldenstrom Macroglobulinemia (GDC-199)

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

La Jolla California 92093

Patients are needed to participate in a clinical research study of ADCT-402 to evaluate Non-Hodgkin Lymphoma

Orange California 92868-3201

A clinical trial seeking patients for a research study of SNS-062

Palo Alto California 94304

A clinical research study of ABT199 for the treatment of Waldenstrom Macroglobulinemia (GDC-199)

View More ▼

Rancho Mirage California 92270

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

Stanford California 94305

TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell Lymphomas

Colorado

Denver Colorado 80218

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

Florida

Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of CLR 131

Georgia

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study of ADCT-402 to evaluate Non-Hodgkin Lymphoma

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of ADCT-402 to evaluate Non-Hodgkin Lymphoma

Illinois

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Maywood Illinois 60153

Patients are needed to participate in a clinical research study of CLR 131

Louisiana

New Orleans Louisiana 70121

Patients are needed to participate in a clinical research study of CLR 131

Massachusetts

Boston Massachusetts 02215

A clinical research study of ABT199 for the treatment of Waldenstrom Macroglobulinemia (GDC-199)

Boston Massachusetts 02215

A clinical trial seeking patients for a research study of SNS-062

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Missouri

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of ADCT-402 to evaluate Non-Hodgkin Lymphoma

New York

New York New York 10065

A clinical research study of ABT199 for the treatment of Waldenstrom Macroglobulinemia (GDC-199)

New York New York 10019

A clinical trial seeking patients for a research study for the treatment of Lymphoid Malignancies, Lymphoma, Hodgkin Lymphoma or Non-hodgkin Lymphoma

New York New York 10065

A clinical trial seeking patients for a research study of SNS-062

New York New York 10065

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

New York New York 10032

Patients are needed to participate in a clinical research study of ADCT-402 to evaluate Non-Hodgkin Lymphoma

View More ▼

Rochester New York 14642

Patients are needed to participate in a clinical research study of CLR 131

Ohio

Cleveland Ohio 44106

Patients are needed to participate in a clinical research study of ADCT-402 to evaluate Non-Hodgkin Lymphoma

Columbus Ohio 43210

A clinical trial seeking patients for a research study of SNS-062

Columbus Ohio 43210

Patients are needed to participate in a clinical research study evaluating ARQ 531

Rhode Island

Providence Rhode Island 02903

Patients are needed to participate in a clinical research study evaluating Rituximab, Bendamustine and Vincristine sulfate liposome injection

South Carolina

Greenville South Carolina 29605

Patients are needed to participate in a clinical research study of ADCT-402 to evaluate Non-Hodgkin Lymphoma

Greenville South Carolina 29605

Patients are needed to participate in a clinical research study of CLR 131

Tennessee

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study evaluating ARQ 531

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

Texas

Houston Texas 77030

A clinical trial seeking patients for a research study of SNS-062

Houston Texas 77030-4009

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

San Antonio Texas 78229

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Utah

Salt Lake City Utah 84112

Patients are needed to participate in a clinical research study evaluating ARQ 531

Virginia

Fairfax Virginia 22031

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Washington

Seattle Washington 98109

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

Seattle Washington 98109

Patients are needed to participate in a clinical research study of CLR 131

Vancouver Washington

A clinical research study of ACP-196 and Pembrolizumab

Wisconsin

Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study of ADCT-402 to evaluate Non-Hodgkin Lymphoma

Australia

Bedford Park South Australia

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

Frankston Victoria 3199

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

Geelong Victoria 3220

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

Melbourne Victoria 3181

Patients are needed to participate in a clinical research study evaluating Belimumab for the treatment of Symptomatic Waldenstroms Macroglobulinaemia

Melbourne Victoria 3002

Patients are needed to participate in a clinical research study evaluating Belimumab for the treatment of Symptomatic Waldenstroms Macroglobulinaemia

View More ▼

Melbourne Victoria 3065

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia

Melbourne Victoria

Patients are needed to participate in a clinical research study evaluating BGB-3111 and Ibrutinib for the treatment of Waldenström's Macroglobulinemia